FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
08/06/2026
Back to search
Official data from USPTO
METEOR BIOTECH
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
METEOR BIOTECH
ST13
US500000079411347Class
5, 9, 42, 44
Filing
79411347
Registration
8090562
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
34
Latest update
08/06/2026
Trademark type
Word
Nice classes
5, 9, 42, 44
Filing date
05/29/2024
Registration date
01/06/2026
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
01/06/2026
Last transaction
08/06/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
4
Owner type
03
Owner location
KR
Examiner
MILMOE, MAUREEN H
Law office
M20
Current location
FILE REPOSITORY (FRANCONIA)
Holders and representatives
Holders
Meteor Biotech Co., Ltd.
Representatives
Minchul Yang STIP Law Group, LLC
Technical classification
Nice Classes
Class 5Class 9Class 42Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Reagents for medical use; Drugs for medical purposesacetaminophen; Enzymes for medical purposes; Enzyme preparations for medical purposes; Nucleic acid sequences for medical and veterinary purposes; Diagnostic chemical preparations for medical purposes for use in DNA analysis; In vitro diagnostic preparations for medical purposes; Diagnostic test reagents for medical or veterinary purposes; Chemical reagents for medical or veterinary purposes; Reagents for use in medical genetic testing
Class 9
Diagnostic apparatus for research laboratory use for DNA analysis; Laboratory devices for DNA sequencingnot for medical purposes; Laboratory devices for analyzing polynucleic acidnot for medical purposes; Reagent containers being chips having multi-well arrays for use with protein analysis apparatus used in chemical analysis and biological analysis for laboratory research use; Laboratory devices for analyzing and extracting genesnot for medical purposes; DNA chips; Laboratory apparatus and instruments for preparing nucleic acid samples; Laboratory apparatusdevices for analyzing protein sequencesnot for medical purposes; Plates having multi-well arrays for analyzing genes for laboratory research use
Class 42
Biomarker discovery services being medical research; Custom design and development of equipment for manufacturing pharmaceuticals; Biological laboratory services relating to the selection and screening of biomarkers in biological tissue samples for scientific research purposes; Design and development of equipment for selection and screening of biomarkers in in biological tissue samples; Scientific research for medical purposes in the area of cancerous diseases; Consulting services in the field of biological sequence processing and analysis for medical research purposes; Research in the field of gene expression analysis; Development of computer software for use with medical equipment; Providing computer software technical support servicestroubleshooting of computer software problems in the field of medical diagnostics; Product development in the field of medical diagnostic devices; Blood testing services for medical research purposes
Class 44
Medical analysis for the diagnosis and treatment of persons; Medical laboratory analysis services relating to the treatment of persons; Medical services relating to the removaltreatment and processing of human blood; RNA or DNA analysis being medical analysis services for the diagnosis of cancer; Medical analysis services for the diagnosis of cancer; Providing information in the field of cancer preventionscreeningdiagnosis and treatment; Provision of genetic testing for medical purposes; Provision of information for medical purposes in the field of gene therapy for cancer treatment; Medical diagnostic services; medical screening; Genetic counseling for medical purposes; Medical analysis services of biomarkers for diagnostic purposes provided by medical laboratories
Publications
History of USPTO decisions and trademark events.
34 publications found
FICS
FINAL DISPOSITION NOTICE SENT TO IB
07/15/2026
FIMP
FINAL DISPOSITION PROCESSED
07/15/2026
OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
05/21/2026
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
05/04/2026
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
05/04/2026
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
04/06/2026
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
01/06/2026
R.PR
REGISTERED-PRINCIPAL REGISTER
01/06/2026
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
11/18/2025
PUBO
PUBLISHED FOR OPPOSITION
11/18/2025
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
11/12/2025
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
10/16/2025
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
10/15/2025
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
10/15/2025
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
10/15/2025
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
09/29/2025
GNFR
FINAL REFUSAL E-MAILED
09/29/2025
CNFR
FINAL REFUSAL WRITTEN
09/29/2025
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
07/05/2025
GNSL
LETTER OF SUSPENSION E-MAILED
07/05/2025
CNSL
SUSPENSION LETTER WRITTEN
07/05/2025
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
07/01/2025
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
07/01/2025
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
07/01/2025
RFNT
REFUSAL PROCESSED BY IB
01/17/2025
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
01/02/2025
RFRR
REFUSAL PROCESSED BY MPU
01/02/2025
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
12/14/2024
CNRT
NON-FINAL ACTION WRITTEN
12/13/2024
DOCK
ASSIGNED TO EXAMINER
12/10/2024
MAFR
APPLICATION FILING RECEIPT MAILED
12/06/2024
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
12/06/2024
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
12/05/2024
Continuous trademark protection
Get notified about every new filing that threatens METEOR BIOTECH or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.